Team
Oncology drug development meets computational cancer biology
Many oncology targets fail in the clinic because preclinical models reflect human disease poorly. We built Gordion to close that gap: patient-derived data analysed by people who have taken drugs into the clinic.
Scientific Advisory Board
Advisors from bench and clinic
Partnered and backed by
